Insiders · Profile

KELER TIBOR

EXECUTIVE VP & CSO at Celldex Therapeutics. Filing since 13 Sep 2010. CIK 0001429931

Company
Date
Role
Action
Shares
Amount
Of holding
7 Dec 2022
EXECUTIVE VP & CSO
Sold, plan not stated
16,860
$622.61K
69.6%
9 Jun 2020
Executive VP & CSO
Bought
5,000
$14.95K
212%
15 Jun 2018
Executive VP & CSO
Bought
16,500
$9.78K
87.4%
2 Sep 2016
Executive VP & CSO
Bought
3,000
$9.96K
18.9%
11 Aug 2011
Sr. VP & CSO
Bought
5,000
$12.52K
46.0%
13 Sep 2010
Sr. VP & CSO
Bought
5,000
$17.60K
opened
6 decisions on file.